• FDA approves first injectable, complete regimen for HIV-1 infection in adults

    1 month ago - By News Medical

    The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
    Read more ...

     

  • F.D.A. Approves Monthly Shots to Treat H.I.V

    1 month ago - By NY Times

    A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.
    Read more ...

     

  • FDA OKs First Long-Acting Injectable HIV Tx

    FDA OKs First Long-Acting Injectable HIV Tx

    1 month ago - By MedPageToday

    The FDA approved the first long-acting injectable therapy for people living with HIV, the agency said late Thursday.
    Injectable cabotegravir-rilpivirine was approved for people with HIV who are virologically suppressed...
    Read more ...

     

  • FDA approves 1st long-acting HIV drug combo, monthly shots

    1 month ago - By ABC News

    U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace daily pills
    Read more ...